ICD-10 Specific code B55: Leishmaniasis
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Leishmaniasis |
French
|
Leishmaniose |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | B50-B64 | Protozoal diseases | |
| 3 | B55 | Leishmaniasis |
Contents
| Code | Title | |
|---|---|---|
| B55.0 | Visceral leishmaniasis | |
| B55.1 | Cutaneous leishmaniasis | |
| B55.2 | Mucocutaneous leishmaniasis | |
| B55.9 | Leishmaniasis, unspecified |
Indicated medicines
| Active Ingredient | Description | |
|---|---|---|
| Minocycline |
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |